Insider · CIK 0002005385
Michael G Erickson
Files at IDXX (IDEXX LABORATORIES INC /DE). First filing Aug 14, 2025, latest Feb 19, 2026.
Michael G Erickson files SEC Form 4 as officer at IDXX (IDEXX LABORATORIES INC /DE). Since Aug 14, 2025, Michael G Erickson has reported 0 open-market buys worth $0 and 2 open-market sells worth $3.6M, the latest filed on Feb 19, 2026.
A track record needs three past buys with six months of prices behind them; Michael G Erickson has 0, so none is measured yet.
The newest scored trade: sold $3.4M of IDXX on Feb 17, 2026, filed Feb 19, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $3.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IDXX: IDEXX LABORATORIES INC /DE
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | IDEXX LABORATORIES INC /DE | $3.4M 5,371 shares | -30% | +73% from low-18% from high | |
| 43Moderate | IDEXX LABORATORIES INC /DE | $264k 406 shares | -3% | +81% from low-4% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 12, 2025 | IDXX IDEXX LABORATORIES, INC. | 407 0.00% of outstanding | $265k | Aug 12, 2025 | none |
Transactions
The newest 50 of 54 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +13,667 | $0.00 | $0 | 13,667 | Mar 3, 2026 |
| Feb 12, 2026 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Incentive Stock Option (right-to-buy)derivative | +162 | $0.00 | $0 | 162 | Mar 3, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +1,191 | $141.60 | $169k | 13,884 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +4,180 | $178.26 | $745k | 18,064 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -456 | $623.76 | $284k | 17,608 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -204 | $625.24 | $128k | 17,404 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -1,288 | $626.26 | $807k | 16,116 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -2,694 | $628.22 | $1.7M | 13,422 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -689 | $629.09 | $433k | 12,733 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -40 | $629.86 | $25k | 12,693 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +719 | $141.60 | $102k | 13,412 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +817 | $178.26 | $146k | 14,229 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +483 | $206.94 | $100k | 14,712 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +183 | $544.08 | $100k | 14,895 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +197 | $505.53 | $100k | 15,092 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -1,191 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -4,180 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Incentive Stock Option (right-to-buy)derivative | -719 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Incentive Stock Option (right-to-buy)derivative | -817 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Incentive Stock Option (right-to-buy)derivative | -483 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Incentive Stock Option (right-to-buy)derivative | -183 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Incentive Stock Option (right-to-buy)derivative | -197 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +92 | $0.00 | $0 | 11,396 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +94 | $0.00 | $0 | 11,490 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +301 | $0.00 | $0 | 11,791 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +184 | $0.00 | $0 | 11,975 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +1,508 | $0.00 | $0 | 13,483 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +184 | $0.00 | $0 | 13,667 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | FTax withholding Common Stock | -974 | $629.35 | $613k | 12,693 | Feb 17, 2026 |
| Feb 12, 2026 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Restricted Stock Unitderivative | +4,739 | $0.00 | $0 | 4,739 | Feb 17, 2026 |
| Feb 12, 2026 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Restricted Stock Unitderivative | +1,580 | $0.00 | $0 | 1,580 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -184 | $0.00 | $0 | 550 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -92 | $0.00 | $0 | 0 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -94 | $0.00 | $0 | 94 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -301 | $0.00 | $0 | 602 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -184 | $0.00 | $0 | 550 | Feb 17, 2026 |
| Feb 14, 2026 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -1,508 | $0.00 | $0 | 0 | Feb 17, 2026 |
| Aug 12, 2025 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -318 | $649.99 | $207k | 11,375 | Aug 14, 2025 |
| Aug 12, 2025 | IDXX IDEXX LABORATORIES INC /DE | SOpen-market sale Common Stock | -88 | $649.85 | $57k | 11,287 | Aug 14, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +69 | $0.00 | $0 | 20,905 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +93 | $0.00 | $0 | 20,998 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +94 | $0.00 | $0 | 21,092 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Common Stock | +301 | $0.00 | $0 | 21,393 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | FTax withholding Common Stock | -177 | $444.53 | $79k | 21,216 | Feb 18, 2025 |
| Feb 13, 2025 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Non-Qualified Stock Option (right-to-buy)derivative | +6,320 | $0.00 | $0 | 6,320 | Feb 18, 2025 |
| Feb 13, 2025 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Incentive Stock Option (right-to-buy)derivative | +217 | $0.00 | $0 | 217 | Feb 18, 2025 |
| Feb 13, 2025 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Restricted Stock Unitderivative | +734 | $0.00 | $0 | 734 | Feb 18, 2025 |
| Feb 13, 2025 | IDXX IDEXX LABORATORIES INC /DE | AGrant or award Restricted Stock Unitderivative | +734 | $0.00 | $0 | 734 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -69 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 14, 2025 | IDXX IDEXX LABORATORIES INC /DE | MOption exercise Restricted Stock Unitderivative | -93 | $0.00 | $0 | 92 | Feb 18, 2025 |
Questions about Michael G Erickson
Answered from the filings on this page, as of the latest one.
Is Michael G Erickson buying or selling?
In the last 12 months Michael G Erickson reported 0 open-market buys worth $0 and 1 open-market sell worth $3.4M on SEC Form 4; the latest was sold $3.4M of IDXX on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael G Erickson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael G Erickson has 0.
Where does Michael G Erickson file Form 4?
Michael G Erickson has filed Form 4 at IDXX (IDEXX LABORATORIES INC /DE) as Executive Vice President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.